Rmb Capital Management, LLC Morpho Sys Ag Transaction History

Rmb Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$21.56 - $30.66 $435,749 - $619,669	-20,211 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$24.81 - $30.33 $320,743 - $392,106	-12,928 Reduced 39.01%	20,211 $573,000
Q3 2020 Nov 10, 2020	SELL	$30.28 - $35.72 $125,904 - $148,523	-4,158 Reduced 11.15%	33,139 $1.04 Million
Q2 2020 Aug 05, 2020	SELL	$24.08 - $33.35 $352,194 - $487,777	-14,626 Reduced 28.17%	37,297 $1.18 Million
Q1 2020 May 11, 2020	SELL	$18.86 - $37.36 $163,478 - $323,836	-8,668 Reduced 14.31%	51,923 $1.28 Million

Q4 2019 Feb 13, 2020	BUY	$26.07 - $36.32 $134,364 - $187,193	5,154 Added 9.3%	60,591 $2.16 Million
Q3 2019 Nov 12, 2019	BUY	$24.18 - $31.58 $401,992 - $525,017	16,625 Added 42.83%	55,437 $1.52 Million
Q2 2019 Aug 13, 2019	BUY	$23.24 - $26.76 $901,990 - $1.04 Million	38,812 New	38,812 $937,000

11.3M

320K

1.1M

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Market Cap $2.47B
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rmb Capital Management, LLC with notifications on news.